The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
An updated histological classification system for multiple sclerosis lesions
Abstract
Multiple sclerosis is a complex and heterogeneous, most likely autoimmune, demyelinating disease of the central nervous system (CNS). Although a number of histological classification systems for CNS lesions have been used by different groups in recent years, no uniform classification exists. In this paper, we propose a simple and unifying classification of MS lesions incorporating many elements of earlier histological systems that aims to provide guidelines for neuropathologists and researchers studying MS lesions to allow for better comparison of different studies performed with MS tissue, and to aid in understanding the pathogenesis of the disease. Based on the presence/absence and distribution of macrophages/microglia (inflammatory activity) and the presence/absence of ongoing demyelination (demyelinating activity), we suggest differentiating between active, mixed active/inactive, and inactive lesions with or without ongoing demyelination. Active lesions are characterized by macrophages/microglia throughout the lesion area, whereas mixed active/inactive lesions have a hypocellular lesion center with macrophages/microglia limited to the lesion border. Inactive lesions are almost completely lacking macrophages/microglia. Active and mixed active/inactive lesions can be further subdivided into lesions with ongoing myelin destruction (demyelinating lesions) and lesions in which the destruction of myelin has ceased, but macrophages are still present (post-demyelinating lesions). This distinction is based on the presence or absence of myelin degradation products within the cytoplasm of macrophages/microglia. For this classification of MS lesions, identification of myelin with histological stains [such as luxol fast blue-PAS] or by immunohistochemistry using antibodies against myelin basic-protein (MBP) or proteolipid-protein (PLP), as well as, detection of macrophages/microglia by, e.g., anti-CD68 is sufficient. Active and demyelinating lesions may be further subdivided into the early and late demyelinating lesions. The former is defined by the presence in macrophages of major and small molecular weight myelin proteins, such as cyclic nucleotide diphosphoesterase (CNP), myelin oligodendrocyte glycoprotein (MOG), or myelin-associated protein (MAG), whereas macrophages in the latter demonstrate merely the presence of the major myelin proteins MBP or PLP. We discuss the histological features and staining techniques required to classify MS lesions, and, in addition, describe the histological hallmarks of cortical pathology and diffuse white matter changes, as well as of remyelination.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Monocytes are recruited to plaques in MS [193] (Fig. 1j-l) and have long been considered to play a pathological role in EAE.”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [193]
In the citing paper
“Neuroinflammation is present in all stages of MS, and a proposed classification of MS lesions relies in part on the presence or absence of microglia in the lesions66.”
From Microglia in neurodegeneration (2018) · cites this paper as [66]
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Self-citationImmunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Self-citationThe relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Self-citationPeterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403 · cited 1×
“Lucchinetti and colleagues have shown extensive cortical inflammatory T-cell infiltrates in early MS lesions (9), however, especially in patients in the progressive disease phase, inflammatory activity in cortical lesions (especially T cells) is, in general, lower than in the adjacent white matter lesions [6, 10, 45].”
BackgroundPathological mechanisms in progressive multiple sclerosis
Mahad, D., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,198
Self-citationRelapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,184
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Self-citationKuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
Self-citation
Research works printed but not linked: 1
- Prineas JW (1985) The neuropathology of multiple sclerosis. In: Koetsier JC (ed) Demyelinating Diseases. Elsevier Science Publishers, Amsterdam, pp 213–257
Cited by
Sorted by citations
Microglia in neurodegeneration
Hickman, S., Izzy, S., Sen, P., Morsett, L., & El Khoury, J. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0242-x · Cited by 1,710
A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis
Absinta, M., Maric, D., Gharagozloo, M., Garton, T., Smith, M. D., Jin, J., Fitzgerald, K. C., Song, A., Liu, P., Lin, J.-P., et al. (2021) · Nature · doi:10.1038/s41586-021-03892-7 · Cited by 768
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes‐Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 799
Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
Lassmann, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03116 · Cited by 711
Self-citationAssessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
Filippi, M., Preziosa, P., Banwell, B., Barkhof, F., Ciccarelli, O., Stefano, N. D., Geurts, J. J. G., Paul, F., Reich, D. S., Toosy, A., et al. (2019) · Brain · doi:10.1093/brain/awz144 · Cited by 607
Machado-Santos, J., Saji, E., Tröscher, A. R., Paunovic, M., Liblau, R., Gabriely, G., Bien, C. G., Bauer, J., & Lassmann, H. (2018) · Brain · doi:10.1093/brain/awy151 · Cited by 548
Self-citationAssociation of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo
Absinta, M., Sati, P., Masuzzo, F., Nair, G., Sethi, V., Kolb, H., Ohayon, J., Wu, T., Cortese, I. C. M., & Reich, D. S. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2399 · Cited by 534
McKenzie, B., Mamik, M. K., Saito, L. B., Boghozian, R., Monaco, M. C., Major, E. O., Lu, J., Branton, W. G., & Power, C. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722041115 · Cited by 525
MAFG-driven astrocytes promote CNS inflammation
Wheeler, M. A., Clark, I. C., Tjon, E. C., Li, Z., Zandee, S. E. J., Couturier, C. P., Watson, B. R., Scalisi, G., Alkwai, S., Rothhammer, V., et al. (2020) · Nature · doi:10.1038/s41586-020-1999-0 · Cited by 501
Self-citationThe immunology of multiple sclerosis
Attfield, K. E., Jensen, L. T., Kaufmann, M., Friese, M. A., & Fugger, L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00718-z · Cited by 380
Höftberger, R., Guo, Y. X., Flanagan, E. P., Lopez-Chiriboga, A. S., Endmayr, V., Hochmeister, S., Joldic, D., Pittock, S. J., Tillema, J. M., Gorman, M., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02132-y · Cited by 379
Self-citationThe Role of Astrocytes in Multiple Sclerosis
Ponath, G. D., Park, C., & Pitt, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00217 · Cited by 378
Luchetti, S., Fransen, N. L., van Eden, C. G., Ramaglia, V., Mason, M., & Huitinga, I. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1818-y · Cited by 355
Neuroinflammation across neurological diseases
Shi, F., & Yong, V. W. (2025) · Science · doi:10.1126/science.adx0043 · Cited by 325
Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis
Berghoff, S. A., Spieth, L., Sun, T., Hosang, L., Schlaphoff, L., Depp, C., Düking, T., Winchenbach, J., Neuber, J., Ewers, D., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00757-6 · Cited by 307
Chu, F., Shi, M., Zheng, C., Shen, D., Zhu, J., Zheng, X., & Cui, L. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.02.015 · Cited by 304
Barcoded viral tracing of single-cell interactions in central nervous system inflammation
Clark, I. C., Gutiérrez-Vázquez, C., Wheeler, M. A., Li, Z., Rothhammer, V., Linnerbauer, M., Sanmarco, L. M., Guo, L., Blain, M., Zandee, S. E. J., et al. (2021) · Science · doi:10.1126/science.abf1230 · Cited by 285
Self-citationThe Kaleidoscope of Microglial Phenotypes
Dubbelaar, M. L., Kracht, L., Eggen, B. J. L., & Boddeke, E. W. G. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01753 · Cited by 260
Association between pathological and MRI findings in multiple sclerosis
Filippi, M., Brück, W., Chard, D., Fazekas, F., Geurts, J. J. G., Enzinger, C., Hametner, S., Kuhlmann, T., Preziosa, P., Rovira, À., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30451-4 · Cited by 252
Self-citationEnvironmental Control of Astrocyte Pathogenic Activities in CNS Inflammation
Wheeler, M. A., Jaronen, M., Covacu, R., Zandee, S., Scalisi, G., Rothhammer, V., Tjon, E. C., Chao, C., Kenison, J. E., Blain, M., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.012 · Cited by 258
Self-citationFard, M. K., van der Meer, F., Sánchez, P., Cantuti-Castelvetri, L., Mandad, S., Jäkel, S., Fornasiero, E. F., Schmitt, S., Ehrlich, M., Starost, L., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7816 · Cited by 249
“In addition, as of yet, no marker for actively ongoing remyelination exists, and consequently, it has thus far not been possible to determine when new myelin sheaths are reformed in MS (33).”
BackgroundSelf-citationBhargava, P., Smith, M. D., Mische, L., Harrington, E., Fitzgerald, K. C., Martin, K. A., Kim, S., Reyes, A. A., Cardona, J. G., Volsko, C. M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129401 · Cited by 243
Molecular biomarkers in multiple sclerosis
Ziemssen, T., Akgün, K., & Brück, W. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1674-2 · Cited by 243
Self-citationCan We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
Kim, M. J., Kang, J. H., Theotokis, P., Grigoriadis, N., & Petratos, S. (2018) · Cells · doi:10.3390/cells8010001 · Cited by 228
Elliott, C., Wolinsky, J. S., Hauser, S. L., Kappos, L., Barkhof, F., Bernasconi, C., Wei, W., Belachew, S., & Arnold, D. L. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458518814117 · Cited by 217
Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
Spiteri, A. G., Wishart, C. L., Pamphlett, R., Locatelli, G., & King, N. J. C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02384-2 · Cited by 216
“Monocytes are recruited to plaques in MS [193] (Fig.”
BackgroundMicroglia in multiple sclerosis: Friend or foe
Guerrero, B. L., & Sicotte, N. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00374 · Cited by 215
Imaging chronic active lesions in multiple sclerosis: a consensus statement
Bagnato, F. R., Sati, P., Hemond, C. C., Elliott, C., Gauthier, S. A., Harrison, D. M., Mainero, C., Oh, J., Pitt, D., Shinohara, R. T., et al. (2024) · Brain · doi:10.1093/brain/awae013 · Cited by 207
Bruton tyrosine kinase inhibitors for multiple sclerosis
Krämer, J., Bar-Or, A., Turner, T. J., & Wiendl, H. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00800-7 · Cited by 206
Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS
Chao, C., Gutiérrez‐Vázquez, C., Rothhammer, V., Mayo, L., Wheeler, M. A., Tjon, E. C., Zandee, S., Blain, M., de Lima, K. A., Takenaka, M. C., et al. (2019) · Cell · doi:10.1016/j.cell.2019.11.016 · Cited by 207
Self-citationPathogenicity of human antibodies against myelin oligodendrocyte glycoprotein
Spadaro, M., Winklmeier, S., Beltrán, E., Macrini, C., Höftberger, R., Schuh, E., Thaler, F., Gerdes, L. A., Laurent, S. A., Gerhards, R., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25291 · Cited by 206
Self-citationInflammatory demyelinating diseases of the central nervous system
Höftberger, R., & Lassmann, H. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00019-5 · Cited by 206
Self-citationFerroptosis promotes T-cell activation-induced neurodegeneration in multiple sclerosis
Luoqian, J., Yang, W., Ding, X., Tuo, Q., Xiang, Z., Zheng, Z., Guo, Y., Li, L., Guan, P., Ayton, S., et al. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00883-0 · Cited by 189
Microglia in multiple sclerosis: protectors turn destroyers
Yong, V. W. (2022) · Neuron · doi:10.1016/j.neuron.2022.06.023 · Cited by 185
Microglia regulation of central nervous system myelin health and regeneration
Kent, S. A., & Miron, V. E. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00907-4 · Cited by 183
Dong, Y., D’Mello, C., Pinsky, W., Lozinski, B. M., Kaushik, D. K., Ghorbani, S., Moezzi, D., Brown, D., Melo, F. C., Zandee, S., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00801-z · Cited by 181
Self-citationB cells in central nervous system disease: diversity, locations and pathophysiology
Jain, R. W., & Yong, V. W. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00652-6 · Cited by 185
Mass Cytometry Imaging for the Study of Human Diseases—Applications and Data Analysis Strategies
Baharlou, H., Canete, N. P., Cunningham, A. L., Harman, A. N., & Patrick, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02657 · Cited by 180
van Nierop, G. P., van Luijn, M. M., Michels, S. S., Melief, M.-J., Janssen, M., Langerak, A. W., Ouwendijk, W. J. D., Hintzen, R. Q., & Verjans, G. M. G. M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1744-4 · Cited by 174
Neurodegeneration in multiple sclerosis
Mey, G. M., Mahajan, K. R., & DeSilva, T. M. (2022) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1583 · Cited by 184
Chu, F., Shi, M., Lang, Y., Shen, D., Jin, T., Zhu, J., & Cui, L. (2018) · Mediators of Inflammation · doi:10.1155/2018/8168717 · Cited by 164
The role of glial cells in multiple sclerosis disease progression
Healy, L. M., Stratton, J. A., Kuhlmann, T., & Antel, J. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00624-x · Cited by 152
Self-citationTargeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis
Wang, J., Wang, J., Wang, J., Yang, B., Weng, Q., & He, Q. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00286 · Cited by 154
The physiology of foamy phagocytes in multiple sclerosis
Grajchen, E., Hendriks, J. J. A., & Bogie, J. F. J. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0628-8 · Cited by 160
van Wageningen, T. A., Vlaar, E., Kooij, G., Jongenelen, C. A. M., Geurts, J. J. G., & van Dam, A.-M. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0850-z · Cited by 147
The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity
Scheu, S., Ali, S., Ruland, C., Arolt, V., & Alferink, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112306 · Cited by 150
Kamma, E., Lasisi, W. O., Libner, C. D., Ng, H. S., & Plemel, J. R. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02408-y · Cited by 157
Meningeal inflammation and cortical demyelination in acute multiple sclerosis
Bevan, R. J., Evans, R., Griffiths, L., Watkins, L. M., Rees, M. I., Magliozzi, R., Allen, I. V., McDonnell, G. V., Kee, R., Naughton, M., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25365 · Cited by 147
Rosa, F. L., Abdulkadir, A., Fartaria, M. J., Rahmanzadeh, R., Lu, P., Galbusera, R., Baraković, M., Thiran, J., Granziera, C., & Cuadra, M. B. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102335 · Cited by 149
Hendrickx, D. A. E., van Scheppingen, J., van der Poel, M., Bossers, K., Schuurman, K. G., van Eden, C. G., Hol, E. M., Hamann, J., & Huitinga, I. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01810 · Cited by 139
Malhotra, S., Costa, C., Eixarch, H., Keller, C. W., Amann, L., Martínez‐Banaclocha, H., Midaglia, L. S., Sarró, E., Machín-Díaz, I., Villar, L. M., et al. (2020) · Brain · doi:10.1093/brain/awaa084 · Cited by 138
Lesion stage-dependent causes for impaired remyelination in MS
Heß, K., Starost, L. J., Kieran, N. W., Thomas, C., Vincenten, M. C. J., Antel, J. P., Martino, G., Huitinga, I., Healy, L. M., & Kuhlmann, T. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02189-9 · Cited by 144
Self-citationIdentification of Chronic Active Multiple Sclerosis Lesions on 3T MRI
Absinta, M., Sati, P., Fechner, A., Schindler, M. K., Nair, G., & Reich, D. S. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5660 · Cited by 134
RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis
Zelic, M., Pontarelli, F., Woodworth, L. A., Zhu, C., Mahan, A. L., Ren, Y., LaMorte, M. J., Gruber, R. C., Keane, A. M., Loring, P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109112 · Cited by 138
Resolution of inflammation during multiple sclerosis
Ruiz, F., Vigne, S., & Pot, C. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00765-0 · Cited by 136
Neely, S. A., Williamson, J. M., Klingseisen, A., Zoupi, L., Early, J. J., Williams, A., & Lyons, D. A. (2022) · Nature Neuroscience · doi:10.1038/s41593-021-01009-x · Cited by 132
Chronic inflammation in multiple sclerosis - seeing what was always there
Matthews, P. M. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0240-y · Cited by 128
Cellular architecture of evolving neuroinflammatory lesions and multiple sclerosis pathology
Kukanja, P., Langseth, C. M., Rubio Rodríguez-Kirby, L. A., Agirre, E., Zheng, C., Raman, A., Yokota, C., Avenel, C., Tiklová, K., Guerreiro-Cacais, A. O., et al. (2024) · Cell · doi:10.1016/j.cell.2024.02.030 · Cited by 124
Neurodegeneration and demyelination in multiple sclerosis
Garton, T. P., Gadani, S. P., Gill, A. J., & Calabresi, P. A. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.025 · Cited by 129
Rahmanzadeh, R., Lu, P., Baraković, M., Weigel, M., Maggi, P., Nguyen, T. D., Schiavi, S., Daducci, A., Rosa, F. L., Schaedelin, S. A., et al. (2021) · Brain · doi:10.1093/brain/awab088 · Cited by 121
Inflammation in multiple sclerosis: consequences for remyelination and disease progression
Klotz, L., Antel, J. P., & Kuhlmann, T. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00801-6 · Cited by 125
Self-citationResearch on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases
Wang, Y., Lv, M.-N., & Zhao, W. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102035 · Cited by 122
Roles and regulation of microglia activity in multiple sclerosis: insights from animal models
Distéfano‐Gagné, F., Bitarafan, S., Lacroix, S., & Gosselin, D. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00709-6 · Cited by 115
Post mortem mapping of connectional anatomy for the validation of diffusion MRI
Yendiki, A., Aggarwal, M., Axer, M., Howard, A. F. D., van Walsum, A. V. C., & Haber, S. N. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119146 · Cited by 116
Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis
Maggi, P., Kühle, J., Schädelin, S., van der Meer, F., Weigel, M., Galbusera, R., Mathias, A., Lu, P., Rahmanzadeh, R., Benkert, P., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012326 · Cited by 112
Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders
Takai, Y., Misu, T., Suzuki, H., Takahashi, T., Okada, H., Tanaka, S., Okita, K., Sasou, S., Watanabe, M., Namatame, C., et al. (2021) · Brain · doi:10.1093/brain/awab102 · Cited by 102
Self-citationMolecular signature of slowly expanding lesions in progressive multiple sclerosis
Jäckle, K., Zeis, T., Schaeren‐Wiemers, N., Junker, A., van der Meer, F., Kramann, N., Stadelmann, C., & Brück, W. (2020) · Brain · doi:10.1093/brain/awaa158 · Cited by 102
Self-citationTeo, W., Caprariello, A. V., Morgan, M. L., Luchicchi, A., Schenk, G. J., Joseph, J. T., Geurts, J. J. G., & Stys, P. K. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016897118 · Cited by 92
Sørensen, P. S., Sellebjerg, F. T., Hartung, H.-P., Montalbán, X., Comi, G., & Tintoré, M. (2020) · Brain · doi:10.1093/brain/awaa145 · Cited by 98
Neuronal loss, demyelination and volume change in the multiple sclerosis neocortex
Carassiti, D., Altmann, D. R., Petrova, N., Pakkenberg, B., Scaravilli, F., & Schmierer, K. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12405 · Cited by 91
The role of TAM family receptors and ligands in the nervous system: From development to pathobiology
Shafit‐Zagardo, B., Gruber, R. C., & DuBois, J. C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.002 · Cited by 89
Gillen, K. M., Mubarak, M., Nguyen, T. D., & Pitt, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00255 · Cited by 88
Resolving the clinico-radiological paradox in multiple sclerosis
Chard, D., & Trip, S. A. (2017) · F1000Research · doi:10.12688/f1000research.11932.1 · Cited by 87
Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα–mediated lipid metabolism
Zhou, X., He, C., Ren, J., Dai, C., Stevens, S. R., Wang, Q., Zamler, D. B., Shingu, T., Yuan, L., Chandregowda, C. R., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci131800 · Cited by 91
Toward Precision Phenotyping of Multiple Sclerosis
Pitt, D., Lo, C. H., Gauthier, S. A., Hickman, R. A., Longbrake, E. E., Airas, L. M., Mao‐Draayer, Y., Riley, C., Jager, P. L. D., Wesley, S., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200025 · Cited by 87
Weider, M., Starost, L. J., Groll, K., Küspert, M., Sock, E., Wedel, M., Fröb, F., Schmitt, C., Baroti, T., Hartwig, A. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03336-3 · Cited by 92
Self-citationA New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis
Rahmanzadeh, R., Galbusera, R., Lu, P., Bahn, E., Weigel, M., Baraković, M., Franz, J., Nguyen, T. D., Spincemaille, P., Schiavi, S., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26441 · Cited by 87
Self-citationMicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis
Morquette, B., Juźwik, C. A., Drake, S., Charabati, M., Zhang, Y., Lécuyer, M., Galloway, D. A., Dumas, A., de Faria, O., Paradis-Isler, N., et al. (2019) · Brain · doi:10.1093/brain/awz245 · Cited by 84
Self-citationMultiplexed imaging of immune cells in staged multiple sclerosis lesions by mass cytometry
Ramaglia, V., Sheikh‐Mohamed, S., Legg, K., Park, C., Rojas, O. L., Zandee, S., Fu, F., Ornatsky, O., Swanson, E. C., Pitt, D., et al. (2019) · eLife · doi:10.7554/elife.48051 · Cited by 83
Self-citationKwong, K. C. N. K., Mollison, D., Meijboom, R., York, E. N., Kampaite, A., Thrippleton, M. J., Chandran, S., & Waldman, A. D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256845 · Cited by 85
Calvi, A., Prados, F., Tur, C., Chard, D., Stutters, J., Angelis, F. D., John, N. A., Williams, T. E., Doshi, A., Samson, R. S., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200144 · Cited by 80
Central Nervous System Remyelination: Roles of Glia and Innate Immune Cells
Baaklini, C. S., Rawji, K. S., Duncan, G. J., Ho, M. F. S., & Plemel, J. R. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00225 · Cited by 88
Starost, L., Lindner, M., Herold, M., Xu, Y. K. T., Drexler, H. C. A., Heß, K., Ehrlich, M., Ottoboni, L., Ruffini, F., Stehling, M., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02217-8 · Cited by 79
Self-citationLopez, J. A., Denkova, M., Ramanathan, S., Dale, R. C., & Brilot, F. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1316 · Cited by 80
Lagumersindez-Denis, N., Wrzos, C., Mack, M., Winkler, A., van der Meer, F., Reinert, M., Hollasch, H., Flach, A., Brühl, H., Cullen, E., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1706-x · Cited by 83
Self-citationIn vivo imaging of chronic active lesions in multiple sclerosis
Calvi, A., Haider, L., Prados, F., Tur, C., Chard, D., & Barkhof, F. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520958589 · Cited by 78
SeXX Matters in Multiple Sclerosis
Gilli, F., DiSano, K. D., & Pachner, A. R. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00616 · Cited by 79
Neuropathological Variability within a Spectrum of NMDAR ‐Encephalitis
Zrzavy, T., Endmayr, V., Bauer, J., Macher, S., Mossaheb, N., Schwaiger, C., Ricken, G., Winklehner, M., Glatter, S., Breu, M., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26223 · Cited by 77
Self-citationCell type mapping reveals tissue niches and interactions in subcortical multiple sclerosis lesions
Lerma-Martin, C., Badia-i-Mompel, P., Ramirez Flores, R. O., Sekol, P., Schäfer, P. S. L., Riedl, C. J., Hofmann, A., Thäwel, T., Wünnemann, F., Ibarra-Arellano, M. A., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01796-z · Cited by 76
“Previous tools for assessing MS pathology have focused on conventional histopathological techniques 10,11,24 , which are limited by the number of antibodies to distinguish cell types.”
Profiling of microglia nodules in multiple sclerosis reveals propensity for lesion formation
van den Bosch, A. M. R., van der Poel, M., Fransen, N. L., Vincenten, M. C. J., Bobeldijk, A. M., Jongejan, A., Engelenburg, H. J., Moerland, P. D., Smolders, J., Huitinga, I., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46068-3 · Cited by 77
Liu, X., Xin, D. E., Zhong, X., Zhao, C., Li, Z., Zhang, L., Dourson, A. J., Lee, L., Mishra, S. V., Bayat, A. E., et al. (2024) · Cell · doi:10.1016/j.cell.2024.04.005 · Cited by 78
7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions
Kolb, H., Absinta, M., Beck, E., Ha, S.-K., Song, Y., Norato, G., Cortese, I. C. M., Sati, P., Nair, G., & Reich, D. S. (2021) · Annals of Neurology · doi:10.1002/ana.26194 · Cited by 80
Simkins, T., Duncan, G. J., & BOURDETTE, D. N. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01110-5 · Cited by 79
Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis
Amadio, S., Parisi, C., Piras, E., Fabbrizio, P., Apolloni, S., Montilli, C., Luchetti, S., Ruggieri, S., Gasperini, C., Pasini, F. L., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01529 · Cited by 74
Paramagnetic Rim Sign in Radiologically Isolated Syndrome
Suthiphosuwan, S., Sati, P., Absinta, M., Guenette, M. D., Reich, D. S., Bharatha, A., & Oh, J. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.0124 · Cited by 76
Owen, J. E., Benediktsdóttir, B., Gíslason, Þ., & Robinson, S. R. (2018) · SLEEP · doi:10.1093/sleep/zsy199 · Cited by 72
Potential biological contributers to the sex difference in multiple sclerosis progression
Álvarez‐Sánchez, N., & Dunn, S. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175874 · Cited by 79
Vincenti, I., Page, N., Steinbach, K., Yermanos, A., Lemeille, S., Nunez, N., Kreutzfeldt, M., Klimek, B., Di Liberto, G., Egervari, K., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl6058 · Cited by 70
Microglia Diversity in Health and Multiple Sclerosis
Zia, S., Rawji, K. S., Michaels, N. J., Burr, M. K., Kerr, B. J., Healy, L. M., & Plemel, J. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.588021 · Cited by 70
The Ins and Outs of Central Nervous System Inflammation—Lessons Learned from Multiple Sclerosis
Ramaglia, V., Rojas, O. L., Naouar, I., & Gommerman, J. L. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-124155 · Cited by 72
Metadata
- Authors
- Kuhlmann, T., Ludwin, S., Prat, A., Antel, J., Brück, W., & Lassmann, H.
- Affiliations
- University Hospital Münster (DE)
- Montreal Neurological Institute and Hospital (CA)
- Centre Hospitalier de l’Université de Montréal (CA)
- Universitätsmedizin Göttingen (DE)
- Medical University of Vienna (AT)
- Corresponding author
- Kuhlmann, Tanja
- Venue
- Acta Neuropathologica
- Published
- 2016-12-17
- Volume
- 133
- Issue
- 1
- Pages
- 13-24
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2562977489
- Cited by
- 692
- References
- 59
- Citations by year
- 2026: 58 · 2025: 87 · 2024: 113 · 2023: 81 · 2022: 99 · 2021: 83 · 2020: 59 · 2019: 51 · 2018: 42 · 2017: 17
- FWCI
- 33.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- GRO (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB-TRR128 B-7, Ku1477/6-1)
- IZKF (KuT3/012/15)
- Austrian Science Fund (FWF Project I 2114-B27)
- CIHR; Quebec, FRQS
- CIHR, Quebec, FRQS
- BMBF, KKNMS
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- multiple sclerosis, histological classification, demyelination, macrophages, microglia, active lesions, myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein, myelin-associated glycoprotein, cortical pathology, remyelination, demyelinating disease, central nervous system lesions, neuropathology
- MeSH terms
- Animals, Humans, Macrophages, Multiple Sclerosis, Microglia, White Matter
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
